Talar-Wojnarowska Renata, Woźniak Beata, Pazurek Marek, Małecka-Panas Ewa
Department of Digestive Tract Diseases, Medical University, Lodz, Poland.
Hepatogastroenterology. 2010 May-Jun;57(99-100):631-4.
BACKGROUND/AIMS: Pancreatic pseudocysts are frequent complication of chronic pancreatitis with incidence rate from 20 to 40%. The aim of our study was to establish a possible correlation between clinical features and outcome of pseudocysts complicating chronic pancreatitis.
We included in the study 37 patients with chronic pancreatitis and pancreatic pseudocysts treated at the Department of Digestive Tract Diseases of Lodz Medical University between 2003-2008. For each patients the following parameters were recorded: number and location of pseudocysts, diameter, kind of treatment, recurrence rate and time of hospitalisation.
The mean size of pancreatic pseudocysts was 7.8 cm (range 2-16 cm). Spontaneous regression was observed in 7 pseudocysts (18.9%), persistence without symptoms and without size enlargement in 9 patients (24.3%). Twenty one (56.8%) pseudocysts required therapeutic intervention: endoscopic procedures (27.1%), surgical treatment (18,.9%) or percutaneous drainage (10.8%). Mean pseudocyst size for conservative treated patients was 4.2 compared to 9.6 for patients with interventional treatment (p < 0.05). The overall recurrence rate was 33.3%. The mean hospital stay of patients treated endoscopically was significantly shorter than those treated surgically (p < 0.01) and shorter than those of percutaneous drainage (p < 0.01).
Pseudocysts treatment in chronic pancreatitis may be effectively achieved by both endoscopic and surgical means. Nonetheless, the endoscopic drainage, with lower hospitalization period, should be considered for initial therapy in each appropriate patients.
背景/目的:胰腺假性囊肿是慢性胰腺炎常见的并发症,发病率为20%至40%。本研究的目的是确定慢性胰腺炎合并假性囊肿的临床特征与预后之间的可能相关性。
我们纳入了2003年至2008年在罗兹医科大学消化道疾病科接受治疗的37例慢性胰腺炎合并胰腺假性囊肿患者。记录每位患者的以下参数:假性囊肿的数量和位置、直径、治疗方式、复发率和住院时间。
胰腺假性囊肿的平均大小为7.8厘米(范围为2至16厘米)。7例假性囊肿(18.9%)出现自发消退,9例患者(24.3%)的假性囊肿持续存在且无症状、大小未增大。21例假性囊肿(56.8%)需要进行治疗干预:内镜手术(27.1%)、手术治疗(18.9%)或经皮引流(10.8%)。保守治疗患者的假性囊肿平均大小为4.2厘米,而介入治疗患者为9.6厘米(p<0.05)。总复发率为33.3%。接受内镜治疗患者的平均住院时间明显短于接受手术治疗的患者(p<0.01),也短于接受经皮引流的患者(p<0.01)。
慢性胰腺炎假性囊肿的治疗可通过内镜和手术方法有效实现。尽管如此,对于每例合适的患者,内镜引流住院时间较短,应考虑作为初始治疗方法。